Korea develops artificial bone for clinical trials

Published: 2004-05-07 06:56:00
Updated: 2004-05-07 06:56:00
The artificial bone, developed by Daewoon Pharm and Bioalpha Co. for the first time in Korea, has obtained official approval from the Korea Food and Drug Administration for clinical trials.

This trials for 126 patients, who require spinal fusion surgery, will be conducted for two years in thre...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.